Skip to content

A multi-center, cluster randomized controlled study comparing usual care and a multidisciplinary intervention such as the DELirium Team Approach program to manage delirium among hospitalized cancer patients

A multi-center, cluster randomized controlled study comparing usual care and a multidisciplinary intervention such as the DELirium Team Approach program to manage delirium among hospitalized cancer patients - DELTA study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030062
Enrollment
9600
Registered
2017-12-11
Start date
2017-12-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignacy

Interventions

Implementation of the DELTA program with six components: (1) education of health care providers, (2) screening of delirium, (3) planning for delirium care, (4) prevention of occurrence and worsening o

Sponsors

National Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Diagnosis of cancer at the primary site in health insurance claims (2) Age >= 50 (3) Hospitalized patients in eligible wards (4) Expected to live for more than 1 month (5) Ability to communicate and write in Japanese (6) Obtained informed consent from the patient or legally acceptable representative

Exclusion criteria

Exclusion criteria: (1) Discharge within 24 hours after admission (2) Severe mental disorder (3) Patients incapable of completing this study as determined by the primary physician or investigator (4) Expected to live for less than 1 month (5) Readmission within length of registration

Design outcomes

Primary

MeasureTime frame
The incidence in events in medical safety such as falls, self-removal of drip infusion or drain tube, restraint

Secondary

MeasureTime frame
Falls, Self-removal of drip infusion or drain tube, Restraint, Barthel Index, Level of nursing care needs, Antipsychotic drug use, Opioid use, Duration of hospital stay, Cost of medical care, Hospital readmission within 1 month after discharge, Mortality within 1 year after discharge

Countries

Japan

Contacts

Public ContactKanno Yusuke

National Cancer Center Division of Psycho-Oncology, Exploratory Oncology Research&Clinical Trial Center

ykanno@east.ncc.go.jp04-7134-7013

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026